Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Assets:
Cash and due from banks	$ 73,322	$ 81,626
Cash at Federal Reserve and other banks	9,514	17,075
Cash and cash equivalents	82,836	98,701
Investment securities:
Marketable equity securities	2,606	2,634
Available for sale debt securities, at fair value (amortized cost of $2,321,608 and $2,384,325)	2,073,888	2,152,504
Held to maturity debt securities, at amortized cost, net of allowance for credit losses of $0	127,811	133,494
Restricted equity securities	17,250	17,250
Loans held for sale	1,346	458
Loans	6,800,695	6,794,470
Allowance for credit losses	(124,394)	(121,522)
Total loans, net	6,676,301	6,672,948
Premises and equipment, net	71,001	71,347
Cash value of life insurance	137,695	136,892
Accrued interest receivable	35,783	36,768
Goodwill	304,442	304,442
Other intangible assets, net	9,522	10,552
Operating leases, right-of-use	26,240	26,133
Other assets	247,046	245,966
Total assets	9,813,767	9,910,089
Deposits:
Noninterest-bearing demand	2,600,448	2,722,689
Interest-bearing	5,387,210	5,111,349
Total deposits	7,987,658	7,834,038
Accrued interest payable	10,224	8,445
Operating lease liability	28,299	28,261
Other liabilities	131,006	145,982
Other borrowings	392,409	632,582
Junior subordinated debt	101,120	101,099
Total liabilities	8,650,716	8,750,407
Commitments and contingencies (Note 9)
Shareholders’ equity:
Preferred stock, no par value: 1,000,000 shares authorized, zero issued and outstanding at March 31, 2024 and December 31, 2023	0	0
Common stock, no par value: 50,000,000 shares authorized; 33,168,770 and 33,268,102 issued and outstanding at March 31, 2024 and December 31, 2023, respectively	696,464	697,349
Retained earnings	630,954	615,502
Accumulated other comprehensive loss, net of tax	(164,367)	(153,169)
Total shareholders’ equity	1,163,051	1,159,682
Total liabilities and shareholders’ equity	$ 9,813,767	$ 9,910,089